title: Flow cytometric analysis of antigen expression in malignant and normal renal cells.
abstract: Flow cytometry allows quantitative analysis of cancer cells. The aim of this study was to make a quantitative study of antigen expression in malignant and normal renal cells in order to find the efficient monoclonal antibodies (mAbs) for labelling renal cancer cells.
  
  
  METHODS
  15 malignant and adjacent normal renal tissues and three renal carcinoma cell lines (ACHN, A704 and CAKI-2) were analyzed. The malignant and normal renal tissues were dissociated mechanically into cell suspension. The mAbs and isotype controls were used for immunochemical labelling. The stained cells were analyzed by flow cytometry.
  
  
  RESULTS
  Renal tumor associated antigen G 250 was frequently detected in malignant renal cells but not in normal renal cells. Renal tumor associated antigen gp200 recognized by 66.4.C2 and PN-15 was frequently detected in malignant cells, normal renal cells and also in all three carcinoma cell lines. Epithelial antigens were strongly positive in normal renal cells. Compared with MOC 31, Ber-EP4 and E 29, W-lD9 was mostly reactive to malignant renal cells. VU-1D9 was strongly positive on ACHN and A704. The carbohydrate carcinoma antigens CA 125, DF3 and Sialyl Lewis(a) were detectable in some of the malignant and normal renal cells. Sialyl Lewis(a) could be weakly detected on ACHN and A 704. Pan-cytokeratins and cytokeratin (CK) 8 were strongly expressed in malignant and normal renal cells and in all three cell lines.
  
  
  CONCLUSIONS
  Our results indicated that G 250, 66.4.Ca, PN-15, VU-1D9, MNF116 and anti-ckg were efficient mAbs for labelling renal cancer cells. Their potential clinical application by flow cytometry should be explored.
authors.affiliation: Department of Urology, North Hospital, CHU of Saint-Etienne, France. Guorong.Li@univ-st-etienne.fr
authors.forename: G
authors.initials: G
authors.lastname: Li
authors.forename: K
authors.initials: K
authors.lastname: Passebosc-Faure
authors.forename: C
authors.initials: C
authors.lastname: Lambert
authors.forename: A
authors.initials: A
authors.lastname: Gentil-Perret
authors.forename: F
authors.initials: F
authors.lastname: Blanc
authors.forename: E
authors.initials: E
authors.lastname: Oosterwijk
authors.forename: J F
authors.initials: JF
authors.lastname: Mosnier
authors.forename: C
authors.initials: C
authors.lastname: Genin
authors.forename: J
authors.initials: J
authors.lastname: Tostain
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000276:immunology; D000941:Antigens / Q000032:analysis*; D018394:CA-125 Antigen / Q000032:analysis; D018395:CA-19-9 Antigen / Q000032:analysis; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000032:analysis; D007668:Kidney / Q000737:chemistry*; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000276:immunology; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D000941:Antigens; D018394:CA-125 Antigen; D018395:CA-19-9 Antigen; D007633:Keratins